Skeletal Muscle Edema in Muscular Dystrophy: Clinical and Diagnostic Implications

Physical Medicine and Rehabilitation Clinics of North America

Volumn 23, Issue 1, 2012, Pages 107-122

  Poliachik, Sandra L ^a   Friedman, Seth D ^a   Carter, Gregory T ^b   Parnell, Shawn E ^a   Shaw, Dennis W ^a  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b Regional Neuromuscular Center   (United States)

Author keywords

MRI; Muscular dystrophy; Myoedema; Neuromuscular disease

Indexed keywords

BECKER MUSCULAR DYSTROPHY; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE MARKER; DUCHENNE MUSCULAR DYSTROPHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; EXERCISE; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCLE DISEASE; MUSCULAR DYSTROPHY; MYOSITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SKELETAL MUSCLE; SKELETAL MUSCLE EDEMA;

ANIMALS; DISEASE PROGRESSION; EDEMA; HUMANS; MAGNETIC RESONANCE IMAGING; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES;

EID: 84855754291     PISSN: 10479651     EISSN: 15581381     Source Type: Journal    
DOI: 10.1016/j.pmr.2011.11.016     Document Type: Review

References (63)

1. Hermans M.C., Pinto Y.M., Merkies I.S., et al. Hereditary muscular dystrophies and the heart. Neuromuscul Disord 2010, 20(8):479-492.
2. Gumerson J.D., Michele D.E. The dystrophin-glycoprotein complex in the prevention of muscle damage. JBiomed Biotechnol 2011, 2011:210797.
3. Waite A., Tinsley C.L., Locke M., et al. The neurobiology of the dystrophin-associated glycoprotein complex. Ann Med 2009, 41(5):344-359.
4. Rajakulendran S., Parton M., Holton J.L., et al. Clinical and pathological heterogeneity in late-onset partial merosin deficiency. Muscle Nerve 2011, 44(4):590-593.
5. Morrison L.A. Dystrophinopathies. Handb Clin Neurol 2011, 101:11-39.
6. Tupler R., Gabellini D. Molecular basis of facioscapulohumeral muscular dystrophy. Cell Mol Life Sci 2004, 61(5):557-566.
7. John J. Grading of muscle power: comparison of MRC and analogue scales by physiotherapists. Medical Research Council. Int J Rehabil Res 1984, 7(2):173-181.
8. Borsato C., Padoan R., Stramere R., et al. Limb-girdle muscular dystrophies type 2A and 2B: clinical and radiological aspects. Basic Appl Myol 2006, 16(1):17-25.
9. Brooke M.H., Griggs R.C., Mendell J.R., et al. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 1981, 4(3):186-197.
10. Brummer D., Walter M.C., Palmbach M., et al. Long-term MRI and clinical follow-up of symptomatic and presymptomatic carriers of dysferlin gene mutations. Acta Myol 2005, 24(1):6-16.
11. Mercuri E., Pichiecchio A., Allsop J., et al. Muscle MRI in inherited neuromuscular disorders: past, present, and future. JMagn Reson Imaging 2007, 25(2):433-440.
12. Schmidt G.P., Reiser M.F., Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skeletal Radiol 2007, 36(12):1109-1119.
13. Wattjes M.P., Kley R.A., Fischer D. Neuromuscular imaging in inherited muscle diseases. Eur Radiol 2010, 20(10):2447-2460.
14. Castillo J., Pumar J.M., Rodriguez J.R., et al. Magnetic resonance imaging of muscles in myotonic dystrophy. Eur J Radiol 1993, 17(3):141-144.
15. Lamminen A.E. Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br J Radiol 1990, 63(756):946-950.
16. Marden F.A., Connolly A.M., Siegel M.J., et al. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol 2005, 34(3):140-148.
17. Brix G., Heiland S., Bellemann M.E., et al. MR imaging of fat-containing tissues: valuation of two quantitative imaging techniques in comparison with localized proton spectroscopy. Magn Reson Imaging 1993, 11(7):977-991.
18. Degardin A., Morillon D., Lacour A., et al. Morphologic imaging in muscular dystrophies and inflammatory myopathies. Skeletal Radiol 2010, 39(12):1219-1227.
19. Cote C., Hiba B., Hebert L.J., et al. MRI of tibialis anterior skeletal muscle in myotonic dystrophy type 1. Can J Neurol Sci 2011, 38(1):112-118.
20. Olsen D.B., Gideon P., Jeppesen T.D., et al. Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI. JNeurol 2006, 253(11):1437-1441.
21. Hasegawa T., Matsumura K., Hashimoto T., et al. Rinsho Shinkeigaku 1992, 32(3):333-335. [in Japanese].
22. Kan H.E., Scheenen T.W., Wohlgemuth M., et al. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2009, 19(5):357-362.
23. Schramm N., Born C., Weckbach S., et al. Involvement patterns in myotilinopathy and desminopathy detected by a novel neuromuscular whole-body MRI protocol. Eur Radiol 2008, 18(12):2922-2936.
24. Fleckenstein J.L. MRI of neuromuscular disease: the basics. Semin Musculoskelet Radiol 2000, 4(4):393-419.
25. Kim H.K., Laor T., Horn P.S., et al. Quantitative assessment of the T2 relaxation time of the gluteus muscles in children with Duchenne muscular dystrophy: a comparative study before and after steroid treatment. Korean J Radiol 2010, 11(3):304-311.
26. Phoenix J., Betal D., Roberts N., et al. Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve 1996, 19(3):302-310.
27. Stramare R., Beltrame V., Dal Borgo R., et al. MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. Radiol Med 2010, 115(4):585-599.
28. Dixon W.T. Simple proton spectroscopic imaging. Radiology 1984, 153(1):189-194.
29. Gloor M., Fasler S., Fischmann A., et al. Quantification of fat infiltration in oculopharyngeal muscular dystrophy: comparison of three MR imaging methods. JMagn Reson Imaging 2011, 33(1):203-210.
30. Wren T.A., Bluml S., Tseng-Ong L., et al. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 2008, 190(1):W8-W12.
31. Leroy-Willig A., Willig T.N., Henry-Feugeas M.C., et al. Body composition determined with MR in patients with Duchenne muscular dystrophy, spinal muscular atrophy, and normal subjects. Magn Reson Imaging 1997, 15(7):737-744.
32. Pichiecchio A., Uggetti C., Egitto M.G., et al. Quantitative MR evaluation of body composition in patients with Duchenne muscular dystrophy. Eur Radiol 2002, 12(11):2704-2709.
33. Huang Y., Majumdar S., Genant H.K., et al. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. JMagn Reson Imaging 1994, 4(1):59-64.
34. Garrood P., Hollingsworth K.G., Eagle M., et al. MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise. JMagn Reson Imaging 2009, 30(5):1130-1138.
35. Friedman SD, Poliachik SL, Carter GT, etal. The MRI spectrum of fascioscapulohumeral muscular dystrophy (FSHD). Muscle Nerve, in press.
36. Kobayashi M., Nakamura A., Hasegawa D., et al. Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging. Muscle Nerve 2009, 40(5):815-826.
37. Vasanawala S.S., Yu H., Shimakawa A., et al. Estimation of liver T*(2) in transfusion-related iron overload in patients with weighted least squares T*(2) IDEAL. Magn Reson Med 2011, [Epub ahead of print].
38. Yu H., McKenzie C.A., Shimakawa A., et al. Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. JMagn Reson Imaging 2007, 26(4):1153-1161.
39. Deconinck N., Dan B. Pathophysiology of Duchenne muscular dystrophy: current hypotheses. Pediatr Neurol 2007, 36(1):1-7.
40. Engvall E., Wewer U.M. The new frontier in muscular dystrophy research: booster genes. FASEB J 2003, 17(12):1579-1584.
41. Gallardo E., Rojas-Garcia R., de Luna N., et al. Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology 2001, 57(11):2136-2138.
42. Confalonieri P., Oliva L., Andreetta F., et al. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study. JNeuroimmunol 2003, 142(1-2):130-136.
43. Frisullo G., Frusciante R., Nociti V., et al. CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI. JClin Immunol 2011, 31(2):155-166.
44. Ogino M., Shiba N., Maeda T., et al. MRI quantification of muscle activity after volitional exercise and neuromuscular electrical stimulation. Am J Phys Med Rehabil 2002, 81(6):446-451.
45. Sesto M.E., Radwin R.G., Block W.F., et al. Anatomical and mechanical changes followingrepetitive eccentric exertions. Clin Biomech (Bristol, Avon) 2005, 20(1):41-49.
46. Ploutz-Snyder L.L., Nyren S., Cooper T.G., et al. Different effects of exercise and edema on T2 relaxation in skeletal muscle. Magn Reson Med 1997, 37(5):676-682.
47. Fisher M.J., Meyer R.A., Adams G.R., et al. Direct relationship between proton T2 and exercise intensity in skeletal muscle MR images. Invest Radiol 1990, 25(5):480-485.
48. Summers R.M., Brune A.M., Choyke P.L., et al. Juvenile idiopathic inflammatory myopathy: exercise-induced changes in muscle at short inversion time inversion-recovery MR imaging. Radiology 1998, 209(1):191-196.
49. Patten C., Meyer R.A., Fleckenstein J.L. T2 mapping of muscle. Semin Musculoskelet Radiol 2003, 7(4):297-305.
50. McNeil P.L., Khakee R. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am J Pathol 1992, 140(5):1097-1109.
51. Carter G.T., Kikuchi N., Abresch R.T., et al. Effects of exhaustive concentric and eccentric exercise on murine skeletal muscle. Arch Phys Med Rehabil 1994, 75(5):555-559.
52. Carter G.T., Kikuchi N., Horasek S.J., et al. The use of fluorescent dextrans as a marker of sarcolemmal injury. Histol Histopathol 1994, 9(3):443-447.
53. Carter G.T., Wineinger M.A., Walsh S.A., et al. Effect of voluntary wheel-running exercise on muscles of the mdx mouse. Neuromuscul Disord 1995, 5(4):323-332.
54. McNeil P.L., Ito S. Molecular traffic through plasma membrane disruptions of cells in vivo. J Cell Sci 1990, 96(Pt 3):549-556.
55. Wineinger M.A., Abresch R.T., Walsh S.A., et al. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. Am J Phys Med Rehabil 1998, 77(1):20-27.
56. Brussee V., Tardif F., Tremblay J.P. Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul Disord 1997, 7(8):487-492.
57. Vilquin J.T., Brussee V., Asselin I., et al. Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise. Muscle Nerve 1998, 21(5):567-576.
58. Straub V., Donahue K.M., Allamand V., et al. Contrast agent-enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy. Magn Reson Med 2000, 44(4):655-659.
59. Kinali M., Arechavala-Gomeza V., Cirak S., et al. Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 2011, 76(4):346-353.
60. Ababneh Z., Beloeil H., Berde C.B., et al. Biexponential parameterization of diffusion and T2 relaxation decay curves in a rat muscle edema model: decay curve components and water compartments. Magn Reson Med 2005, 54(3):524-531.
61. Budzik J.F., Le Thuc V., Demondion X., et al. In vivo MR tractography of thigh muscles using diffusion imaging: initial results. Eur Radiol 2007, 17(12):3079-3085.
62. Kermarrec E., Budzik J.F., Khalil C., et al. In vivo diffusion tensor imaging and tractography of human thigh muscles in healthy subjects. AJR Am J Roentgenol 2010, 195(5):W352-W356.
63. Zaraiskaya T., Kumbhare D., Noseworthy M.D. Diffusion tensor imaging in evaluation of human skeletal muscle injury. J Magn Reson Imaging 2006, 24(2):402-408.